Warby Parker Inc.
WRBY- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001504776
In the last 90 days, Warby Parker Inc. insiders filed 0 open-market purchases and 2 sales; 304 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; Gardner Russo & Quinn is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:51 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net income for FY2025: $1.64M (0.2% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Feb 28, 2024 | Feb 28, 2023 | Mar 17, 2022 |
| Revenue | $871.9M | $771.3M | $669.8M | $598.1M | $540.8M |
| Cost of revenue | $401.3M | $344.5M | $304.5M | $257.1M | $223.0M |
| Gross profit | $470.6M | $426.8M | $365.2M | $341.1M | $317.7M |
| Selling, general and administrative | $475.9M | $456.9M | $437.2M | $452.3M | $461.4M |
| Operating income | -$5.34M | -$30.1M | -$72.0M | -$111.2M | -$143.7M |
| Income tax | $1.40M | $875.0K | $433.0K | $497.0K | $263.0K |
| Net income | $1.64M | -$20.4M | -$63.2M | -$110.4M | -$144.3M |
| EPS, basic | $0.01 | $-0.17 | $-0.54 | $-0.96 | $-2.21 |
| EPS, diluted | $0.01 | $-0.17 | $-0.54 | $-0.96 | $-2.21 |
| Weighted shares, basic | 122.7M | 120.4M | 117.4M | 114.9M | 71.2M |
| Weighted shares, diluted | 125.1M | 120.4M | 117.4M | 114.9M | 71.2M |
| Margins and growth | |||||
| Gross margin | 54.0% | 55.3% | 54.5% | 57.0% | 58.8% |
| Operating margin | -0.6% | -3.9% | -10.7% | -18.6% | -26.6% |
| Net margin | 0.2% | -2.6% | -9.4% | -18.5% | -26.7% |
| Revenue growth, year over year | +13.0% | +15.2% | +12.0% | +10.6% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Feb 28, 2024 | Feb 28, 2023 | Mar 17, 2022 |
| Cash and equivalents | $286.4M | $254.2M | $216.9M | $208.6M | $256.4M |
| Accounts receivable | $3.29M | $1.95M | $1.78M | $1.44M | $992.0K |
| Inventory | $44.5M | $52.3M | $62.2M | $68.8M | $57.1M |
| Total current assets | $352.4M | $326.0M | $298.6M | $294.6M | $328.0M |
| Property, plant and equipment | $187.4M | $170.5M | $152.3M | $138.6M | $112.2M |
| Total assets | $720.9M | $676.5M | $580.3M | $568.7M | $440.6M |
| Accounts payable | $32.0M | $23.5M | $22.5M | $20.8M | $30.9M |
| Total current liabilities | $150.1M | $130.4M | $127.1M | $129.6M | $118.1M |
| Total liabilities | $353.2M | $336.4M | $278.5M | $282.1M | $154.6M |
| Shareholders' equity | $367.7M | $340.1M | $301.8M | $286.6M | $286.0M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 27, 2025 | Feb 28, 2024 | Feb 28, 2023 | Mar 17, 2022 |
| Operating cash flow | $110.8M | $98.7M | $61.0M | $10.4M | -$32.0M |
| Capital expenditures | $67.0M | $64.0M | $53.7M | $60.2M | $48.5M |
| Free cash flow | $43.7M | $34.7M | $7.32M | -$49.8M | -$80.5M |
| Depreciation and amortization | $50.3M | $45.9M | $38.6M | $31.9M | $21.9M |
| Stock-based compensation | $34.5M | $47.3M | $70.5M | $98.0M | $107.1M |
| Share buybacks | – | – | $0 | $0 | $8.09M |
| Investing cash flow | -$67.0M | -$66.0M | -$54.7M | -$60.2M | -$48.5M |
| Financing cash flow | -$12.0M | $4.96M | $2.87M | $3.29M | $23.0M |
| Net change in cash | $32.2M | $37.3M | $8.31M | -$47.8M | -$57.7M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 4.0% | 6.1% | 10.5% | 16.4% | 19.8% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 9, 2021 | 113.2M | – | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.